Dulaglutide‐related bullous pemphigoid in a patient with type 2 diabetes: A case report-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Dulaglutide‐related bullous pemphigoid in a patient with type 2 diabetes: A case report

Published:2019-12 Issue:12 Volume:19 Page:1289-1290
ISSN:1444-1586
Container-title:Geriatrics & Gerontology International
language:en
Short-container-title:Geriatr. Gerontol. Int.

Author:

Fukuda Gen¹,Yoshida Tomohiko¹²,Hirayama Arisa³,Umezawa Yoshinori³,Takemoto Minoru¹²^ORCID

Affiliation:

1. Department of Diabetes, Metabolism and EndocrinologyInternational University of Health and Welfare Ichikawa Hospital Chiba Japan

2. Department of Diabetes, Metabolism and Endocrinology, School of MedicineInternational University of Health and Welfare Chiba Japan

3. Department of DermatologyThe Jikei University School of Medicine, Skin Sciences Tokyo Japan

Publisher

Wiley

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ggi.13799

Reference5 articles.

1. Association of Bullous Pemphigoid With Dipeptidyl-Peptidase 4 Inhibitors in Patients With Diabetes

2. Bullous Pemphigoid and Dipeptidyl Peptidase 4 Inhibitors: A Disproportionality Analysis Based on the Japanese Adverse Drug Event Report Database

3. HLA-DQB1*03:01 as a Biomarker for Genetic Susceptibility to Bullous Pemphigoid Induced by DPP-4 Inhibitors

4. Synergistic contribution of CD14 and HLA loci in the susceptibility to Buerger disease

5. Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The first report of leukocytoclastic vasculitis induced by once-weekly subcutaneous semaglutide;Current Medical Research and Opinion;2024-08-02

2. Rare cutaneous adverse reactions associated with GLP-1 agonists: a review of the published literature;Archives of Dermatological Research;2024-05-25

3. Bullous pemphigoid triggered by dulaglutide: a case report and a review of the literature;Dermatology Reports;2023-06-06

4. Adverse drug reactions of GLP-1 agonists: A systematic review of case reports;Diabetes & Metabolic Syndrome: Clinical Research & Reviews;2022-03

5. An Uncommon Case of Dulaglutide-Related Morbilliform Drug Eruption;Cureus;2022-01-23

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3